Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival. (Q45876550)

PubMed publication ID

18391751

17 December 2017

http://europepmc.org/abstract/MED/18391751

title

Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

Lawrence Kingsley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

10

James J Goedert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

8

Joseph B Margolick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

11

Stephen J O'Brien

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

1

Sher L Hendrickson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

author name string

George W Nelson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

John P Phair

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

James Lautenberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

Roger Detels

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

Lisa P Jacobson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

PubMed publication ID

18391751

17 December 2017

http://europepmc.org/abstract/MED/18391751

published in

Journal of Acquired Immune Deficiency Syndromes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

page(s)

263-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants

14 May 2020

cites work

1 reference

12 December 2020

Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type

1 reference

12 December 2020

Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans

1 reference

12 December 2020

The influence of HLA genotype on AIDS

1 reference

12 December 2020

Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy.

1 reference

12 December 2020

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

1 reference

12 December 2020

The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment

1 reference

12 December 2020

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

12 December 2020

Human genes that limit AIDS.

1 reference

12 December 2020

MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients

1 reference

12 December 2020

Association of the CCR5delta32 mutation with improved response to antiretroviral therapy

1 reference

12 December 2020

Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression

1 reference

12 December 2020

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy

1 reference

12 December 2020

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

12 December 2020

MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study

1 reference

12 December 2020

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

1 reference

12 December 2020

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection

1 reference

12 December 2020

Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy

1 reference

12 December 2020

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry

1 reference

12 December 2020

Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen

1 reference

12 December 2020

An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children

1 reference

12 December 2020

Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters

1 reference

12 December 2020

Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy

1 reference

12 December 2020

Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy

1 reference

12 December 2020

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion

1 reference

12 December 2020

The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

1 reference

12 December 2020

Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression

1 reference

12 December 2020

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

1 reference

12 December 2020

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

1 reference

12 December 2020

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

1 reference

12 December 2020

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients

1 reference

12 December 2020

Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response

1 reference

12 December 2020

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

12 December 2020

A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals

1 reference

12 December 2020

CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy

1 reference

12 December 2020

Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1

1 reference

12 December 2020

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients

1 reference

12 December 2020

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

12 December 2020

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

1 reference

12 December 2020

Modulating influence on HIV/AIDS by interacting RANTES gene variants

1 reference

12 December 2020

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

12 December 2020

Worldwide transmission of drug-resistant HIV

1 reference

12 December 2020

Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals

1 reference

12 December 2020

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

1 reference

12 December 2020

The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity

1 reference

12 December 2020

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.

1 reference

12 December 2020

Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts

1 reference

12 December 2020

Therapeutic drug monitoring in HIV infection: current status and future directions

1 reference

12 December 2020

10.1097/QAI.0B013E31816FDC5F

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

release_bfhhhdoi6ng3darwldwfrcoziq

14 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bfhhhdoi6ng3darwldwfrcoziq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6986260&resulttype=core&format=json

14 May 2020

PubMed publication ID

18391751

1 reference